Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy and hypertension

R B Devereux1, G de Simone, A Ganau

  • 1Division of Cardiology, New York Hospital, Cornell Medical Center, NY 10021.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fructose and salt induce sex- and ovary dependent cardiac hypertrophy in Dahl salt-sensitive rats.

Frontiers in cardiovascular medicine·2026
Same author

Cross-linked carboxymethyl cellulose and silk proteins for dry eye disease management and corneal wound healing: in vivo and in vitro results.

European review for medical and pharmacological sciences·2026
Same author

Dissection of Nitric Oxide binding pathway in Nitrobindins reveals hidden structural details.

International journal of biological macromolecules·2025
Same author

Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation.

Stem cell research & therapy·2024
Same author

Erratum to "Second Consensus on Treatment of Patients Recently Diagnosed with Mild Hypertension and Low Cardiovascular Risk". [YMCD 45/10 (October 2020) 100653].

Current problems in cardiology·2021
Same author

Home mobile radiography service in the COVID-19 era.

European review for medical and pharmacological sciences·2021

Left ventricular (LV) hypertrophy in hypertensive patients significantly increases cardiovascular risk. Assessing LV geometry aids in risk stratification and guides treatment decisions for better patient outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • Left ventricular (LV) mass in hypertensive patients is influenced by arterial pressure, volume load, arterial waveform, body size, and non-hemodynamic factors.
  • The LV can adapt through concentric or eccentric hypertrophy, or concentric remodeling, altering cardiac structure in response to hypertension.

Purpose of the Study:

  • To investigate the prognostic value of left ventricular geometry in hypertensive patients.
  • To determine if LV geometry assessment improves cardiovascular risk stratification beyond traditional measures.

Main Methods:

  • Echocardiography and other techniques were used to measure LV mass and geometry.
  • Analysis included correlation with cardiovascular morbid events and comparison with WHO hypertension severity classification.

Related Experiment Videos

Main Results:

  • Eccentric and concentric LV hypertrophy are associated with a two- to four-fold increase in cardiovascular morbid events compared to normal LV geometry.
  • LV geometry assessment provides stronger prognostic prediction than indirect measures of target organ status in hypertension.

Conclusions:

  • Evaluation of LV geometry is crucial for accurate cardiovascular risk stratification in hypertensive patients.
  • Assessing LV geometry can enhance clinical decision-making regarding the initiation and type of treatment for hypertension.